Avançar para navegação principal Avançar para pesquisar Avançar para conteúdo principal

Neutralizing anti-granulocyte macrophage-colony stimulating factor autoantibodies recognize post-translational glycosylations on granulocyte macrophage-colony stimulating factor years before diagnosis and predict complicated Crohn's disease

  • Arthur Mortha*
  • , Romain Remark
  • , Diane Marie Del Valle
  • , Ling Shiang Chuang
  • , Zhi Chai
  • , Inês Alves
  • , Catarina Azevedo
  • , Joana Gaifem
  • , Jerome Martin
  • , Francesca Petralia
  • , Kevin Tuballes
  • , Vanessa Barcessat
  • , Siu Ling Tai
  • , Hsin Hui Huang
  • , Ilaria Laface
  • , Yeray Arteaga Jerez
  • , Gilles Boschetti
  • , Nicole Villaverde
  • , Mona D. Wang
  • , Ujunwa M. Korie
  • Joseph Murray, Rok Seon Choung, Takahiro Sato, Renee M. Laird, Scott Plevy, Adeeb Rahman, Joana Torres, Chad Porter, Mark S. Riddle, Ephraim Kenigsberg, Salomé S. Pinho, Judy H. Cho, Miriam Merad, Jean Frederic Colombel, Sacha Gnjatic
*Autor correspondente para este trabalho

Resultado de pesquisa: Contribuição em revista científica › Artigo › revisão de pares

71 Citações (Scopus)

Resumo

Background & Aims: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (aGMAbs) are detected in patients with ileal Crohn's disease (CD). Their induction and mode of action during or before disease are not well understood. We aimed to investigate the underlying mechanisms associated with aGMAb induction, from functional orientation to recognized epitopes, for their impact on intestinal immune homeostasis and use as a predictive biomarker for complicated CD. Methods: We characterized using enzyme-linked immunosorbent assay naturally occurring aGMAbs in longitudinal serum samples from patients archived before the diagnosis of CD (n = 220) as well as from 400 healthy individuals (matched controls) as part of the US Defense Medical Surveillance System. We used biochemical, cellular, and transcriptional analysis to uncover a mechanism that governs the impaired immune balance in CD mucosa after diagnosis. Results: Neutralizing aGMAbs were found to be specific for post-translational glycosylation on granulocyte macrophage-colony stimulating factor (GM-CSF), detectable years before diagnosis, and associated with complicated CD at presentation. Glycosylation of GM-CSF was altered in patients with CD, and aGMAb affected myeloid homeostasis and promoted group 1 innate lymphoid cells. Perturbations in immune homeostasis preceded the diagnosis in the serum of patients with CD presenting with aGMAb and were detectable in the noninflamed CD mucosa. Conclusions: Anti-GMAbs predict the diagnosis of complicated CD long before the diagnosis of disease, recognize uniquely glycosylated epitopes, and impair myeloid cell and innate lymphoid cell balance associated with altered intestinal immune homeostasis.

Idioma originalInglês
Páginas (de-até)659-670
Número de páginas12
RevistaGastroenterology
Volume163
Número de emissão3
DOIs
Estado da publicaçãoPublicado - set. 2022
Publicado externamenteSim

Impressão digital

Mergulhe nos tópicos de investigação de “Neutralizing anti-granulocyte macrophage-colony stimulating factor autoantibodies recognize post-translational glycosylations on granulocyte macrophage-colony stimulating factor years before diagnosis and predict complicated Crohn's disease“. Em conjunto formam uma impressão digital única.

Citação